The chronic inflammatory skin condition psoriasis was associated with the risk of major depression, although the risk was unrelated to the severity of the disorder, according to a new article.
A phase II clinical trial shows that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care for the chronic skin condition. Psoriasis is an immune-mediated disease that causes itchy, dry and red skin. It also increases a patient's risk for depression, heart disease and diabetes, among other conditions. The disease affects nearly 3 percent of the world's population.
Eczema is one of the most common skin conditions in the United States, and research into treatment is ongoing. Learn about using probiotics to treat eczema
Biological treatment of psoriasis shows a good efficacy in clinical trials. Since most analyses have focused on short-term outcomes of single biological agents, little has been known about long-term...
A new study examines people with severe eczema and finds that a genetic mutation may cause the condition. The study also paves the way for a new treatment.
For the roughly 7 percent of adults who live with atopic dermatitis, a common form of eczema, a new study reports a little good news: Despite recent findings to the contrary, the skin condition is...
Affecting more than 6 million Americans, chronic plaque psoriasis manifests as patches of red, scaly skin most frequently on the scalp, elbows and knees.
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided...
High blood sugar levels can cause a number of different skin conditions. In this article, learn about these conditions and how they might be prevented.
